2018 News

Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014
DateTitle 
05/03/18IRIDEX Announces 2018 First Quarter Financial Results
MOUNTAIN VIEW, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq:IRIX) today reported financial results for the first quarter ended March 31, 2018. First Quarter Highlights Cyclo G6™ product revenue increased approximately 50% year-over-year Shipped a record 11,600 G6 probes Shipped 99 G6 laser systems Presence at American Society of Cataract and Refractive Surgery (ASCRS) and Association for Research in Vision and Ophthalmology (ARVO) meetings i... 
Printer Friendly Version
04/19/18IRIDEX to Report First Quarter 2018 Financial Results on May 3, 2018
MOUNTAIN VIEW, Calif., April 19, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq:IRIX) today announced the Company will release financial results for the first quarter 2018 after the close of trading on Thursday, May 3, 2018.  The Company’s management team will host a corresponding conference call beginning at 2:00 p.m. PT / 5:00 p.m. ET. Investors interested in listening to the conference call may do so by dialing (844) 707-0665 for domestic callers or (703) 326-3030 for international ... 
Printer Friendly Version
04/16/18IRIDEX Announces Appointment of Maria Sainz and David Bruce to its Board of Directors
MOUNTAIN VIEW, Calif., April 16, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq:IRIX) today announced the appointment of Maria Sainz and David Bruce to the Company’s Board of Directors effective as of April 13, 2018.  Ms. Sainz and Mr. Bruce will both join the Compensation Committee. Ms. Sainz will also join the Nominating and Governance Committee.  Concurrent with these additions, George Marcellino will depart from the Board of Directors to focus on his new role as IRIDEX’s Vice Presiden... 
Printer Friendly Version
03/20/18Iridex Receives CE Mark for Transilluminated Probe
The leading-edge G-Probe Illuminate™ glaucoma device with built-in transillumination now available in Europe MOUNTAIN VIEW, Calif., March 20, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq:IRIX) is pleased to announce the availability of the G-Probe Illuminate™ device in Europe. The probe, now with CE mark, offers combined transillumination and laser fiber for targeted transscleral cyclophotocoagulation (CPC). The G-Probe Illuminate received FDA clearance and was launched in early 2017. ... 
Printer Friendly Version
03/08/18IRIDEX Announces 2017 Fourth Quarter and Full Year Financial Results
Shipped Record Cyclo G6™ Laser Systems and G6 Probes MOUNTAIN VIEW, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the fourth quarter and full year ended December 30, 2017. Fourth Quarter Highlights Fourth quarter 2017 revenue for Cyclo G6™ glaucoma laser platform increased approximately 17% year-over-year Shipped a record 133 Cyclo G6 glaucoma laser systems Shipped a record 10,600 G6 probes Fourt... 
Printer Friendly Version
02/27/18IRIDEX to Present at the 30th Annual Roth Conference
MOUNTAIN VIEW, Calif., Feb. 27, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq:IRIX) today announced the Company plans to participate in the upcoming 30th Annual Roth Conference in Orange County, CA. IRIDEX’s management is scheduled to present on Tuesday, March 13, 2018 at 11:00am PT.  Interested parties may access a live and archived webcast of the presentation at www.IRIDEX.com.  About IRIDEX IRIDEX Corporation is a worldwide leader in developing, manufacturing, and marketing innov... 
Printer Friendly Version
02/23/18IRIDEX Issues Voluntary Recall of TruFocus LIO Premiere™ Laser Indirect Ophthalmoscope
Updates Preliminary Financial Results for 2017 Fourth Quarter and Full Year MOUNTAIN VIEW, Calif, Feb. 23, 2018 (GLOBE NEWSWIRE) -- On February 23, 2018, IRIDEX Corporation (“Company”) initiated a voluntary recall of a specific laser accessory called the TruFocus LIO Premiere™.  The LIO is a headmounted indirect ophthalmoscope that connects to an IRIDEX laser console and is used to view and perform laser treatments on a patient’s eye.  There are 104 TruFocus LIO Premiere units at customer sit... 
Printer Friendly Version
02/20/18IRIDEX to Report Fourth Quarter and 2017 Financial Results on March 8, 2018
MOUNTAIN VIEW, Calif., Feb. 20, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq:IRIX) today announced the Company will release financial results for the fourth quarter and full year 2017 after the close of trading on Thursday, March 8, 2018.  The Company’s management team will host a corresponding conference call beginning at 2:00 p.m. PT / 5:00 p.m. ET. Investors interested in listening to the conference call may do so by dialing (844) 707-0665 for domestic callers or (703) 326-3030 fo... 
Printer Friendly Version
01/09/18IRIDEX Announces Infringement Lawsuit Against Quantel
MOUNTAIN VIEW, Calif., Jan. 09, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ:IRIX) announced today that it has filed a lawsuit against Quantel Medical, S.A., Quantel USA, Inc., and Quantel, S.A. in the U.S. District Court for the Northern District of California.  The lawsuit alleges that Quantel products infringe U.S. Patent No. 7,771,417, that Quantel breached an earlier agreement between the parties, and that Quantel has infringed Iridex's MicroPulse® trademark, Registration No. 45501... 
Printer Friendly Version
01/08/18IRIDEX Announces Preliminary Operational and Financial Results for 2017 Fourth Quarter and Full Year
MOUNTAIN VIEW, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq:IRIX) today provided preliminary operational and financial results for the fourth quarter and full year ended December 30, 2017. Highlights Total revenue for the fourth quarter of 2017 expected to be $11.0 to $11.1 million Total revenue for 2017 expected to be $42.3 to $42.4 million Approximately 133 Cyclo G6 glaucoma laser systems and 10,600 G6 probes were shipped in the fourth quarter of 2017 ... 
Printer Friendly Version


logo aa0logo agslogo ascrslogo asrslogo esrs0logo euretina